Fact-checked by Grok 2 weeks ago

Tinea capitis

Tinea capitis is a superficial infection of the and shafts, primarily affecting prepubertal children and caused by keratinophilic fungi such as species of and . It typically presents with pruritic, scaly patches of alopecia, and may evolve into inflammatory variants featuring pustules, nodules, or formation with secondary bacterial infection. Transmission occurs via direct person-to-person or fomites like combs, hats, and , with higher incidence in crowded environments and among certain ethnic groups due to characteristics facilitating fungal invasion. In , Trichophyton tonsurans accounts for the majority of cases, reflecting an endothrix pattern of infection, whereas ectothrix infections from Microsporum canis or Microsporum audouinii predominate in and other regions. Recent epidemiological shifts, including increased adult cases and variations linked to migration, underscore the need for ongoing . Diagnosis relies on clinical examination, supplemented by , , or Wood's for confirmation, as misdiagnosis can delay and promote spread. Management necessitates oral antifungal therapy, with or terbinafine as first-line agents for 6-8 weeks, since topical treatments fail to penetrate hair follicles adequately. Adjunctive selenium sulfide shampoo reduces infectivity, and measures emphasize hygiene and screening in outbreaks, particularly in schools.

Etiology and Pathogenesis

Causative Fungi

Tinea capitis is caused by keratinophilic fungi, predominantly species within the genera Trichophyton and Microsporum, which invade the hair shaft and follicle. These anthropophilic (human-adapted) or zoophilic (animal-adapted) pathogens produce arthroconidia—infectious spores formed by hyphal fragmentation—that facilitate hair invasion. In endothrix infections, arthroconidia form inside the hair shaft without destroying the cuticle, as seen with Trichophyton species; ectothrix infections feature a sheath of spores around the exterior, typically from Microsporum species. Trichophyton tonsurans, an anthropophilic endothrix dermatophyte, predominates in urban North American and UK settings, accounting for 88-96% of cultured isolates in recent US surveillance data. This species rose to dominance in the United States during the 1970s, supplanting prior ectothrix agents like Microsporum audouinii through increased person-to-person spread in densely populated areas. Anthropophilic fungi such as T. tonsurans exhibit host adaptation, resulting in chronic, less inflammatory infections compared to zoophilic counterparts. Microsporum canis, a zoophilic ectothrix primarily hosted by and dogs, remains a key where animal contact is common, comprising the majority of cases per multicenter reports. It produces abundant ectothrix spores on the surface, often eliciting pronounced inflammatory responses due to zoonotic mismatch. Regional variants include violaceum, another anthropophilic endothrix agent prevalent in immigrant communities from or the , identified in up to 20-30% of cases in affected cohorts. Culture-based identification confirms these distributions, with T. tonsurans exceeding 90% in pediatric isolates from 2010-2020 studies.

Transmission Mechanisms

Tinea capitis spreads primarily through direct with infected individuals or animals, facilitating person-to-person or zoonotic . Close physical , such as in households or play settings, allows dermatophytes to transfer from to , while sharing personal items like combs, hairbrushes, hats, or towels provides a common vector for anthropophilic species such as . Zoonotic cases often involve direct handling of infected pets, particularly cats and dogs carrying , which accounts for a significant portion of animal-derived infections in regions where such strains predominate. Indirect transmission occurs via fomites, including contaminated tools, , , or environmental surfaces like mats, where arthroconidia shed from infected hairs remain infectious. These spores demonstrate environmental persistence, remaining viable for months on inanimate objects under favorable conditions such as warmth and , thereby sustaining outbreaks even without ongoing direct exposure. Following exposure, the for tinea capitis typically spans 1 to 3 weeks, during which fungal elements invade hair follicles without immediate clinical signs, allowing silent dissemination in high-contact settings like schools or communal living arrangements. Crowding exacerbates risk by increasing opportunities for both direct interpersonal transfer and contamination among susceptible children.

Pathophysiological Processes

Dermatophyte fungi causing tinea capitis invade the and follicles by secreting proteolytic enzymes, including keratinases, which hydrolyze into peptides and for fungal nutrition. This enzymatic degradation enables hyphal penetration of the non-viable keratinized layers, with the fungus colonizing the shaft and follicle interior while evading deeper viable invasion due to barriers and immune factors. The process begins at arthroconidia or hyphal fragments adhering to the , followed by radial growth along the follicle, where the fungus exploits the nutrient-rich environment of newly forming in the bulb. Invasion patterns differ by fungal species: ectothrix involves hyphae forming arthrospores that sheath the exterior of the shaft beneath the , often preserving the shaft integrity initially but leading to surface destruction; endothrix features hyphal fragmentation into spores entirely within the shaft, compromising internal structure and causing brittleness. These distinctions arise from species-specific adaptations, such as Microsporum spp. favoring ectothrix via external spore production, while predominantly causes endothrix by internal proliferation, resulting in fragility, breakage at the follicular orifice, or complete shaft dissolution. Follicular colonization disrupts the , inducing dystrophic changes and mechanical through enzymatic weakening rather than direct host cell . Host response is predominantly cell-mediated, involving T-lymphocyte activation and cytokine release (e.g., IL-2, IFN-γ) that recruit neutrophils and macrophages to form granulomatous inflammation. In children, immune immaturity—characterized by underdeveloped Th1 responses and delayed antigen recognition—permits initial fungal proliferation with minimal early inflammation, followed by a in severe cases manifesting as , a boggy from exaggerated delayed-type . This T-cell-driven response, while aimed at fungal clearance, contributes to tissue damage via inflammatory mediators, potentially leading to follicular scarring if unresolved. Endemic exposure may modulate responses, with repeated low-level contact fostering partial immunity that limits severity in adults compared to children's naive systems.

Clinical Features

Primary Symptoms

Tinea capitis primarily manifests as pruritus, , and alopecia in circumscribed patches. Patients commonly report itching and observe dry, flaky with breakage or , often revealing broken hair stubs resembling black dots within the affected areas. Inflammatory variants may feature tender, pustular eruptions or a boggy, suppurative mass accompanied by regional . scalp colonization occurs in some individuals, particularly in high-prevalence settings, without evident or discomfort. Lesions typically originate as small erythematous papules around hair follicles and expand centrifugally if untreated, potentially enlarging affected zones over weeks to months. Systemic signs such as low-grade fever arise rarely, usually in association with pronounced inflammatory responses.

Disease Patterns

Tinea capitis manifests in distinct clinical patterns influenced by the mode of fungal invasion—ectothrix or endothrix—and host immune response, resulting in non-inflammatory or inflammatory presentations. Ectothrix patterns, where arthroconidia sheath the exterior of the hair shaft, typically produce the gray patch variant, featuring circumscribed areas of alopecia with fine scaling and short, broken hairs that appear grayish due to surface spores; these hairs fluoresce bright green under Wood's lamp examination, most commonly from Microsporum species infections. In contrast, endothrix invasion, with hyphae and arthroconidia confined within the hair shaft, yields the black dot pattern, characterized by hairs fracturing at or near the scalp surface, leaving pinpoint black dots amid mild scaling and patchy alopecia; this does not fluoresce under Wood's lamp and predominates in Trichophyton tonsurans cases. Favus represents a specialized non-inflammatory variant linked to schoenleinii, forming yellow, cup-shaped crusts (scutula) around hair follicles amid scarring alopecia, though it remains rare in Western populations due to shifts in ecology. Inflammatory patterns arise from exaggerated to fungal antigens, culminating in formation—a boggy, tender tumefaction with overlying pustules, crusting, and purulent discharge that can simulate pyogenic bacterial abscesses or , often resolving with scarring if untreated. These inflammatory responses occur across invasion types but correlate more with zoophilic fungi or overwhelming anthropophilic loads. While pediatric cases predominate with balanced non-inflammatory and inflammatory forms, adult tinea capitis proves rarer—comprising under 2% of instances—and skews toward severe inflammatory phenotypes like , potentially due to altered sebum production and immune dynamics in post-pubertal scalps. Such patterns underscore the need for pattern-specific to guide , as ectothrix forms may respond partially to adjunctive topicals while endothrix variants necessitate .

Differential Considerations

Alopecia areata presents with well-demarcated patches of non-inflammatory alopecia, often featuring exclamation-point hairs, without scaling or broken hair shafts characteristic of tinea capitis; it is typically reversible and lacks infectious etiology.
Seborrheic dermatitis manifests as diffuse, greasy yellow scales across the scalp with minimal to no alopecia, differing from the patchy, drier scaling and hair breakage in tinea capitis.
Psoriasis of the scalp involves thicker, silvery plaques that often extend beyond the hairline to the or ears, with involvement in up to 50% of cases, contrasting the more localized alopecia and potential inflammatory response in tinea capitis.
Bacterial or exhibits pustular or crusted lesions with purulent discharge and rapid progression, unlike the slower-evolving, less exudative patches of tinea capitis; secondary bacterial superinfection can complicate fungal cases but is distinguished by culture.
capitis features visible nits or lice along hair shafts with pruritus from infestation, absent in tinea capitis where ectothrix or endothrix hair invasion leads to breakage without macroscopic parasites.
causes irregular, traction-like alopecia from habitual pulling, lacking the scaling, inflammation, or infectious signs of tinea capitis.
Less common mimics include dissecting (scarring alopecia with tufted hairs) and secondary (moth-eaten alopecia with systemic symptoms), which require exclusion via history and due to overlapping patchy .
Empirical discriminators for tinea capitis include associated pruritus, posterior , and black-dot or stubbed hairs, with confirmation via revealing hyphae or fluorescence under Wood's lamp for species.

Diagnosis

Clinical Evaluation

Clinical evaluation of tinea capitis begins with a detailed history to identify risk factors and symptom onset. Clinicians inquire about duration of scalp symptoms such as pruritus, , or alopecia, which typically develop insidiously over weeks. history is critical, including contact with infected family members, schoolmates, or animals like cats and dogs carrying dermatophytes such as Microsporum canis; crowded living conditions or poor hygiene may also be elicited, as these facilitate fomites like shared combs or hats. Physical examination focuses on scalp inspection for characteristic lesions, including circumscribed patches of alopecia with fine scaling, , and broken hair stubs resembling black dots in endothrix infections. Hairs may appear dull or bent, with surrounding varying from mild to severe pustules or crusting. The hair pull test assesses fragility: gentle traction on affected hairs yields breakage at the scalp surface, distinguishing from normal shedding. Wood's lamp examination under ultraviolet light may reveal bright blue-green fluorescence in ectothrix infections caused by Microsporum species, aiding rapid clinical suspicion, though non-fluorescent Trichophyton infections predominate in many regions. Red flags include formation—a boggy, tender, pus-draining inflammatory mass signaling hypersensitivity reaction—which warrants urgent assessment to mitigate risks of secondary bacterial infection or scarring alopecia.

Laboratory Methods

Laboratory confirmation of tinea capitis typically involves microscopic examination of (KOH) preparations from scalp scrapings or plucked hairs, which reveal septate hyphae and arthroconidia within or around the hair shaft. This provides rapid results within minutes but has variable sensitivity, reported at approximately 70-90% in experienced hands, depending on sample quality and observer expertise, with lower specificity in some studies due to potential artifacts or non-dermatophyte elements. Fungal remains the gold standard for definitive and species identification, requiring inoculation of specimens onto Sabouraud dextrose agar or similar media, with growth typically observable in 1-4 weeks under appropriate incubation conditions at 25-30°C. Cultures confirm involvement, such as or species, and allow assessment of antifungal , though false negatives occur in up to 30-50% of cases due to prior topical treatments or low fungal burden. Molecular techniques, including (PCR) assays targeting DNA, offer faster identification than culture, with results available in hours and higher sensitivity for detecting low-level infections, particularly in endothrix patterns common in urban settings. Real-time has demonstrated superior performance over conventional methods in comparative studies, identifying species like T. tonsurans with minimal sample processing, though availability is limited to specialized laboratories and costs remain higher. Histopathological examination via is infrequently required, reserved for atypical presentations mimicking inflammatory conditions like or bacterial , where periodic acid-Schiff () staining highlights hyphae invading the and . sensitivity is high when fungi are present but adds procedural risks and is not routine due to the adequacy of less invasive methods.

Diagnostic Challenges

Tinea capitis diagnosis is hindered by asymptomatic carriers, who harbor dermatophytes on the without visible lesions and serve as reservoirs for , particularly within households where carriage rates among contacts can reach 16% initially, with persistence in up to 41% despite of index cases. These carriers often evade routine clinical detection, complicating outbreak control and requiring targeted mycological screening of at-risk individuals to identify subclinical infections. Diagnostic tests like (KOH) yield false negatives in low-burden or early infections, where sparse hyphae or arthroconidia are overlooked, as well as in inflammatory variants such as , where obscures fungal elements. Fungal culture, the gold standard for species , demands 2-4 weeks for growth, delaying confirmation and risking missed non-dermatophyte mimics or ectothrix patterns with minimal shedding. In adults, underdiagnosis stems from the condition's rarity—comprising less than 3% of cases—and clinicians' low index of suspicion, often attributing subtle scaling or alopecia to androgenetic or seborrheic etiologies rather than pursuing dermatophyte-specific tests like Wood's lamp or trichoscopy. Atypical presentations, including diffuse without alopecia, further contribute to misattribution, with studies noting increased adult incidence potentially reflecting diagnostic oversight rather than true rarity. Empirical therapy without culture confirmation heightens risks in resistance-endemic areas, such as those with dominance, where unverified treatment may select for resistant strains or fail against alternative pathogens, as evidenced by observational showing frequent systemic antifungals prescribed sans diagnostics in pediatric cohorts.00189-5/fulltext) This approach overlooks species-specific susceptibilities, potentially prolonging and fostering outbreaks, underscoring the need for mycological prior to prolonged courses.

Treatment Approaches

Systemic Antifungals

, an oral antifungal derived from species, remains a first-line for tinea capitis, particularly effective against infections by binding to precursors in actively dividing cells, thereby inhibiting fungal and facilitating deposition in shafts for prolonged exposure. In pediatric patients, dosing is weight-based at 20-25 mg/kg/day of microsized formulation, administered with fatty food to enhance absorption, typically for 6-8 weeks to achieve mycological cure rates of approximately 70-80% overall, with higher efficacy (up to 88%) against species in randomized trials but lower against (around 50%). A 2024 confirmed griseofulvin's role but noted its longer treatment duration compared to alternatives. Terbinafine, an that inhibits synthesis by blocking squalene epoxidase, offers a shorter treatment course and superior efficacy against species, with complete cure rates of 80-92% in clinical trials versus 72% for . Pediatric dosing follows body weight: 62.5 mg daily for <25 kg, 125 mg for 25-35 kg, and 250 mg for >35 kg, given once daily for 2-4 weeks, as supported by randomized controlled trials showing noninferiority or superiority to , particularly in shorter regimens. Recent guidelines and 2024 analyses increasingly favor terbinafine as preferred for its faster mycological clearance and fewer gastrointestinal side effects, though efficacy varies by species. Alternatives include , a inhibiting 14α-demethylase to disrupt production, dosed at 5-6 mg/kg once weekly for 3-6 weeks in children, achieving cure rates of 70-85% in open-label studies but with less robust trial data than or terbinafine. , another with similar mechanism, is given at 5 mg/kg/day for 2-4 weeks or in pulse regimens (e.g., 5 mg/kg/day for one week per month), effective in refractory cases with cure rates around 80% but requiring acidic beverages for absorption optimization in . All systemic agents necessitate baseline and periodic due to rare risks, with overall cure rates reaching 80-95% when adherence is maintained and species-specific selection guides therapy.

Topical and Supportive Therapies

Topical antifungal shampoos, such as 2% or 1-2.5% selenium sulfide formulations, function primarily as adjunctive agents in tinea capitis treatment to diminish viable arthroconidia on the surface. By reducing fungal burden, these shampoos applied 2-3 times weekly limit transmissibility to contacts and may shorten the period of contagious shedding. However, their limited into follicles precludes standalone against endothrix infections, where dermatophytes reside within the shaft, necessitating concurrent systemic antifungals for cure. Supportive interventions emphasize hygiene to curb reinfection, including daily cleansing, disinfection of combs and brushes, and avoidance of shared headwear or grooming tools that harbor spores. In inflammatory variants, featuring pustular swellings and boggy plaques from to fungal antigens, short-term oral corticosteroids like (1-2 mg/kg/day tapered over 1-2 weeks) are sometimes added to dampen acute and mitigate risks of cicatricial alopecia, though randomized evidence shows no significant improvement in long-term mycologic or clinical outcomes over antifungals alone. Clinical studies confirm adjunctive topicals accelerate superficial spore clearance—evidenced by negative cultures in 4-6 weeks when paired with orals—but fail to resolve deep-seated without follicular-targeting agents, underscoring their non-curative .

Treatment Efficacy and Resistance

Systemic antifungals such as terbinafine and demonstrate high efficacy in treating tinea capitis, with mycological cure rates often exceeding 80% in pediatric populations when dosed appropriately for 4-6 weeks. Terbinafine shows particular superiority against , the predominant causative agent in many regions, achieving up to 88% mycological cure and 76% clinical cure in follow-up studies. remains effective against species but requires longer durations, with pooled cure rates around 73% post-treatment. rates range from 10-20%, frequently linked to untreated contacts facilitating reinfection rather than primary failure. Antifungal resistance, particularly to terbinafine in T. tonsurans isolates, remains rare in tinea capitis cases but has been documented in isolated reports, often involving epoxidase gene mutations. Such appears more prevalent in chronic dermatophytoses outside the scalp, with laboratory data indicating variable minimum inhibitory concentrations in resistant strains. In scalp infections, T. tonsurans responds robustly to terbinafine in most instances, though monitoring for non-response is advised in endemic areas. Recent studies from 2023-2024 highlight the viability of shorter pulse regimens, such as pulses (one to three cycles), which yield comparable to continuous terbinafine while potentially reducing cumulative exposure. These approaches emphasize screening and treating household members to curb , with pulse therapy showing median durations of 4 weeks in some cohorts. However, empirical overprescription of systemic agents without confirmatory cultures risks unnecessary , as oral antifungals like terbinafine can elevate liver enzymes in susceptible patients, necessitating baseline and periodic monitoring. This underscores the causal importance of verification to avoid iatrogenic harm in presumptive diagnoses.

Prevention Strategies

Individual Measures

Individuals at risk of tinea capitis, particularly children in households or communities with active cases, should avoid sharing personal items such as combs, brushes, hats, towels, and bedding to prevent transmission of arthroconidia from infected hair shafts. Regular handwashing with and after contact with potentially infected individuals or animals is recommended to reduce and direct transmission risks. In settings with ongoing exposure, such as outbreaks, prophylactic use of shampoos containing 2% applied daily or twice weekly has demonstrated efficacy in reducing infection incidence among household contacts, with one study reporting a significant decrease in clinically evident cases when used for 4-8 weeks. or shampoos, applied for 5-10 minutes before rinsing twice weekly, serve as adjunctive measures to diminish fungal load and shedding, though they do not eradicate endothrix infections alone. Household pets suspected as reservoirs, such as cats or dogs showing signs like alopecia or scaling, require veterinary evaluation and to eliminate zoonotic transmission sources, as accounts for a notable proportion of pediatric cases in endemic areas. Maintaining short hair lengths is not evidence-based for prevention, as it does not address arthroconidia persistence in follicles or environment. Compliance with these measures relies on consistent application, with empirical data indicating lower reinfection rates in adherent families.

Community and Environmental Controls

In community settings, particularly schools and households, control of tinea capitis outbreaks involves prompt screening of close contacts, including family members and classmates, to identify carriers shedding arthroconidia. Wood's light examination aids detection of ectothrix infections from anthropophilic dermatophytes like , facilitating early intervention in group surveys, though its utility is limited for non-fluorescent endothrix species such as , which predominate in many regions. Exclusion policies prioritize treatment initiation over prolonged isolation; children starting systemic antifungals like or terbinafine, combined with selenium sulfide shampoo to reduce spore load, may return to school immediately, as infectivity decreases rapidly with therapy adherence. Some guidelines specify exclusion only until the day after treatment commences, balancing contagion risk with educational continuity. Contact tracing extends to household evaluation, with recommendations for use among exposed individuals to curb secondary , supported by data from familial clusters showing reduced incidence through such prophylaxis. Environmental decontamination targets fomites like combs, brushes, and , where viable spores persist; these should be soaked in 1:10 diluted bleach () for 10-20 minutes or treated with 2% phenolic disinfectants, followed by rinsing, as demonstrated effective against arthroconidia in laboratory assays. Irreparably contaminated items warrant disposal to prevent reinfection cycles. No is available for tinea capitis, necessitating reliance on active in high-prevalence groups, such as preadolescent children in overcrowded urban or institutional settings, where periodic culture from suspect cases informs outbreak thresholds and .

Epidemiology

Global and Regional Prevalence

Tinea capitis primarily affects prepubertal children, with peak incidence occurring between 3 and 7 years of age. Global prevalence varies widely due to differences in causative species, population density, and hygiene practices, with higher rates reported in resource-limited settings. In urban areas of developed countries, such as the United States and United Kingdom, incidence among at-risk pediatric groups, including children of African or Afro-Caribbean descent, ranges from 3% to 10%. In contrast, prevalence in parts of Africa and Asia often exceeds 10%, reaching up to 20% or more in school-aged children in endemic regions with overcrowding and limited access to care. Etiological patterns have shifted geographically over time; since the 1950s, has emerged as the predominant pathogen in and urban , largely supplanting due to changes in transmission dynamics and migration. In and parts of , remains common, often linked to zoonotic sources like cats. Regional surveys indicate lower overall rates in (0.2% to 2.6%) compared to (up to 87.7% in isolated studies, though typically 10-20% in community screenings). Adult cases account for 3% to 11% of tinea capitis infections worldwide, though epidemiological reviews highlight an increasing trend, potentially driven by , close contact with infected children, and evolving pathogen distribution. This rise is noted in both immunocompetent and vulnerable adults, with higher proportions in postmenopausal women and regions with endemic pediatric transmission.

Demographic Risk Factors

Tinea capitis primarily affects prepubescent children aged 3 to 7 years, with facilitated by close contact in group settings such as schools, daycare centers, or households with multiple siblings. Crowded living conditions exacerbate risk through enhanced sharing and direct scalp-to-scalp contact, independent of strain. Populations of sub-Saharan African descent, including African American children in the United States, show disproportionately higher incidence rates, causally linked to hair grooming practices like tight braiding, weaves, or application of occlusive oils and pomades that trap arthroconidia on the scalp. Low socioeconomic status further amplifies vulnerability via associated overcrowding, limited access to hygiene resources, and delayed medical intervention, as evidenced in cohort studies of Medicaid-enrolled children. Gender distribution lacks strong disparity, with most epidemiological data indicating approximate equality or minimal predominance attributable to behavioral factors like rough play rather than differences. Immunocompromise rarely triggers pediatric cases, contrasting with adults where conditions like or use more frequently enable dissemination. Zoonotic acquisition elevates risk among children in rural settings or those owning pets, particularly cats asymptomatically carrying , which penetrates hair shafts via grooming behaviors. Prior to the mid-20th century, predominated as the etiologic agent of tinea capitis in the United States and , accounting for the majority of cases among children. By the 1950s and 1960s, a shift occurred toward as the primary pathogen, driven by increased immigration from endemic areas in and the , where anthropophilic dermatophytes like T. tonsurans circulate widely among human hosts. This transition altered disease patterns, as T. tonsurans typically causes endothrix infections with minimal and patchy scaling, facilitating higher rates of asymptomatic carriage and intraschool transmission compared to the ectothrix, fluorescent infections of earlier eras. The rise of T. tonsurans contributed to resurgent outbreaks in the , particularly in urban schools serving African-American communities; a 1997 California population study documented epidemic-level incidence, with rates exceeding 200 cases per 100,000 children in affected northern counties and disproportionately impacting Black school-aged youth. Similar epidemic dynamics emerged in amid migration flows, with T. tonsurans cases doubling in some urban centers by the early . In developing regions, tinea capitis has shown persistent high incidence historically, with prevalence reaching 10-20% in schoolchildren across parts of , , and , sustained by socioeconomic factors like overcrowding and limited hygiene infrastructure favoring anthropophilic species such as T. tonsurans and T. violaceum. Unlike industrialized areas where incidence declined post-shift through improved diagnostics and targeted interventions, endemicity endures in low-resource settings, with little etiological evolution due to ongoing human-to-human transmission.

Complications and Prognosis

Potential Complications

Untreated inflammatory tinea capitis, particularly the form characterized by boggy, pustular nodules, can lead to scarring alopecia with permanent due to follicular destruction from intense inflammation and fibrosis. This arises from prolonged untreated infection allowing unchecked invasion and host inflammatory response, with higher risk in cases involving species. Secondary bacterial superinfection frequently complicates untreated lesions, especially in , where disrupted skin barrier facilitates entry of pathogens like , resulting in , , or formation that exacerbates tissue damage. Id reactions, or dermatophytids, present as distant, pruritic eczematous eruptions (e.g., vesicles or papules on ) triggered by to fungal antigens, occurring in response to ongoing without resolution. In immunocompromised hosts, such as those with or on immunosuppressive therapy, untreated tinea capitis carries a risk of disseminated , involving deeper tissue invasion or systemic spread, though this remains rare compared to superficial involvement. Visible alopecia and scaling from untreated disease contribute to , with affected children experiencing distress, reduced , and social withdrawal due to the conspicuous nature of lesions.

Long-term Outcomes

With prompt systemic , tinea capitis achieves high rates of complete clinical and mycological in the majority of cases, particularly when initiated early before extensive develops. Follow-up studies report sustained cure rates of 80-90% at 3-6 months post-therapy with agents like terbinafine or , though monitoring for culture negativity is essential to confirm eradication. Hair regrowth in non-inflammatory cases typically begins within several months and completes in 6-12 months after fungal clearance, restoring normal appearance without intervention. In contrast, scarring alopecia from severe inflammatory forms, such as , is irreversible and affects up to 25% of those patients, resulting in permanent bald patches due to follicular destruction. Recurrence post-treatment is primarily attributable to reinfection rather than persistent , with reported rates of 10-20% linked to environmental or untreated household . Successful eliminates the active , preventing progression to chronicity, and no persistent carrier state develops long-term in treated individuals when follow-up confirms negativity.

Historical Context

Early Descriptions

The earliest recorded descriptions of conditions resembling tinea capitis appear in ancient medical texts. , in his work De Medicina around 25–30 CE, detailed a suppurative infection characterized by , crusting, and , which aligns with the inflammatory form known as ; he termed similar dry, scaly scalp eruptions porrigo. The Latin term tinea, evoking a or worm devouring material, was applied by and later physicians like (c. 129–216 CE) to creeping, destructive skin lesions including those on the , though without recognition of fungal causation. In medieval , favus—a severe, chronic variant of tinea capitis marked by honeycomb-like scabs (scutula) and foul on the —gained recognition as a distinct entity, often linked to poor and crowding; it was documented in clinical observations from the onward, predating microscopic identification. The fungal etiology emerged in the . In 1839, Lucas Schönlein and Remak independently observed thread-like fungi in favus crusts, naming the Achorion schönleinii (later reclassified as Trichophyton schoenleinii), shifting understanding from parasitic insects or humoral imbalances to microbial invasion. Raymond Sabouraud advanced this in the 1890s by culturing multiple species from tinea capitis cases at Hôpital Saint-Louis, establishing their role in scalp ringworm and differentiating strains like .

Modern Developments

The introduction of oral in 1958 marked a pivotal advance in tinea capitis management, replacing hazardous methods like epilation and enabling effective systemic treatment of endothrix infections. This antifungal agent, derived from species, achieved high cure rates by disrupting fungal , with clinical studies demonstrating mycological clearance in over 90% of cases when administered for 6-8 weeks. Its widespread adoption in the late led to sharp declines in prevalence in regions like , where scalp ringworm cases nearly vanished by the 1960s. In the 1970s, emerged as the dominant pathogen in Western countries, particularly the , shifting from species and necessitating adjustments in diagnostic due to its endothrix pattern with fewer arthroconidia. This change, linked to urban population dynamics and close-contact transmission, increased inflammatory presentations like and reduced the efficacy of topical adjuncts alone, reinforcing reliance on prolonged courses. Recent decades have seen integration of , with () assays enabling rapid species identification from scalp swabs or hairs within hours, surpassing traditional and in sensitivity (up to 95%) for T. tonsurans and . These tools facilitate and outbreak , as evidenced by 2024 studies confirming PCR's role in confirming non-response cases. Antifungal resistance, though rare in tinea capitis to date, prompts ongoing , with networks tracking minimal inhibitory concentrations for terbinafine and amid rising elsewhere, such as terbinafine-resistant T. indotineae strains. A 2024 review highlighted the need for susceptibility testing in recalcitrant pediatric cases to guide alternatives like . From 2023 onward, heightened recognition of adult tinea capitis—comprising 3-11% of global cases, often in immunocompromised or postmenopausal individuals—has emphasized zoonotic and anthropophilic risks, with studies reporting increased inflammatory variants in urban adults. Shorter regimens using terbinafine (2-4 weeks at 250 mg daily for adults) have gained favor over , showing comparable or superior mycological cure rates (80-90%) in meta-analyses, particularly for T. tonsurans, while improving adherence.

References

  1. [1]
    Tinea Capitis - StatPearls - NCBI Bookshelf
    Tinea capitis, also known as ringworm or herpes tonsurans infection, is a fungal infection of the scalp hair. It is caused primarily by the dermatophyte species ...Continuing Education Activity · History and Physical · Treatment / Management
  2. [2]
    Ringworm (scalp) - Symptoms & causes - Mayo Clinic
    Jan 22, 2022 · Ringworm of the scalp (tinea capitis) is a rash caused by a fungal infection. It usually causes itchy, scaly, bald patches on the head.
  3. [3]
    Ringworm and Fungal Nail Infections Basics - CDC
    Apr 24, 2024 · Ringworm (tinea) is a common fungal infection of the hair (tinea capitis), skin, or nails (onychomycosis). It gets its name because it causes a ...Symptoms · Fungal Diseases · Site Index · Emerging Types of Ringworm
  4. [4]
    Tinea Capitis: Current Status - PMC - NIH
    Sep 6, 2016 · Tinea capitis is a common infection of the scalp hair caused by dermatophyte fungi and occurring predominantly in children.Missing: definition symptoms
  5. [5]
    Comprehensive Review of Tinea Capitis in Adults - PubMed Central
    May 16, 2024 · Tinea capitis is a fungal infection of the scalp and hair caused by dermatophyte molds, that most often affects children and may also affect adults.
  6. [6]
    Ringworm (scalp) - Diagnosis & treatment - Mayo Clinic
    Treatment for ringworm of the scalp requires a prescription-strength antifungal medication taken by mouth. The first-choice medication is usually griseofulvin ( ...Treatment · Preparing For Your... · Questions For Your DoctorMissing: definition | Show results with:definition
  7. [7]
    Ringworm (tinea) - World Health Organization (WHO)
    Jun 19, 2025 · Tinea capitis (scalp ringworm) affects the scalp and can cause itching, redness and hair loss. It is mainly seen in children.Scope Of The Problem · Symptoms · Risk Factors
  8. [8]
    Tinea Capitis: Practice Essentials, Pathophysiology, Etiology
    Oct 2, 2024 · It has been suggested that predilection of tinea capitis for children (see Epidemiology) results from the presence of Malassezia furfur ...Practice Essentials · Pathophysiology · Etiology · Epidemiology
  9. [9]
    Tinea Capitis - DynaMed
    Nov 8, 2024 · T. tonsurans is the most common dermatophyte causing tinea capitis in the United States, United Kingdom, Brazil, Jamaica, and in parts of ...
  10. [10]
    Tinea Capitis - an overview | ScienceDirect Topics
    In North America and the United States, Trichophyton tonsurans is the predominant organism (88.1%16 for the USA and 76% for Canada).17 In The Netherlands, the ...
  11. [11]
    [PDF] Tinea Capitis and Tinea Corporis with a Severe Inflammatory ...
    T. tonsurans predominantly causes tinea capitis. In the Uk and USA 50–90% (15) and 95.8% (17) of tinea capitis were in- fections with T. tonsurans, while in ...
  12. [12]
    Tinea capitis: epidemiology, diagnosis, treatment, and control
    Selenium sulfide shampoo, prednisone, and oral antibiotics are frequently used as adjunctive therapy.Missing: definition symptoms<|separator|>
  13. [13]
    Epidemiology of tinea capitis in Europe: current state and ... - PubMed
    Microsporum canis, a zoophilic dermatophyte, is still the most common reported causative agent of tinea capitis in Europe. The countries reporting the highest ...Missing: species US
  14. [14]
    Tinea Capitis Due to Microsporum canis
    Nov 20, 2021 · M. canis is a zoophilic fungus that is often acquired from domestic animals. The patient's parents reported no pets at home but mentioned that ...
  15. [15]
    Tinea Capitis - Elsevier
    REVIEW ARTICLE. Tinea Capitis. N Rebollo, AP López-Barcenas, and R Arenas ... An open study of tinea capitis in 50 children treated with a 2-week course ...
  16. [16]
    [PDF] Predominance of Trichophyton tonsurans causing tinea capitis
    Besides, endothrix (77.0%) was the most prevalent type of hair invasion. Conclusion: The results revealed the predominance of T. tonsurans, as a causative agent.
  17. [17]
    Clinical Overview of Ringworm and Fungal Nail Infections - CDC
    Jul 15, 2024 · How it spreads · Direct skin contact with people and animals who are infected. · Sharing personal items (e.g., towels, clothing, bedding).Missing: mechanisms | Show results with:mechanisms
  18. [18]
    Tinea Capitis (Ringworm of the Scalp) | Red Book
    Tinea capitis can occur in association with tinea corporis. Examination of ... The dermatophyte organism remains viable for prolonged periods on fomites ...
  19. [19]
    Dermatophyte Infections - AAFP
    Jan 1, 2003 · Dermatophytes are spread by direct contact from other people (anthropophilic organisms), animals (zoophilic organisms), and soil (geophilic ...
  20. [20]
    Ringworm—Child Care and Schools | Pediatric Patient Education
    Mar 31, 2023 · Incubation period: 1 to 3 weeks but can be shorter. Contagious period: A child with ringworm of the skin is infectious as long as the fungus ...
  21. [21]
    How Long Is Ringworm Contagious If Treated vs. Untreated?
    Mar 9, 2018 · What is the incubation period? ... The incubation period for ringworm in humans is usually one to two weeks. Because the fungal spores are present ...How it spreads · Incubation period · Healing time with treatment...
  22. [22]
    Tinea Capitis: Current Status | Mycopathologia
    Sep 6, 2016 · Tinea capitis is a common infection of the scalp hair caused by dermatophyte fungi and occurring predominantly in children.<|separator|>
  23. [23]
  24. [24]
    Current knowledge of host response in human tinea - Brasch - 2009
    Jun 8, 2009 · This is followed by an inflammatory response mediated by a plentitude of cytokines and receptors, comprising innate as well as acquired immunity ...<|separator|>
  25. [25]
    Management of tinea capitis in childhood - PMC - NIH
    It is a reactive phenomenon that may be the result of a cell-mediated immune response to the dermatophyte, triggered by the antimycotic treatment. Topical ...
  26. [26]
    Dermatophyte infection: from fungal pathogenicity to host immune ...
    Apart from invasion against skin barrier, host immune responses to dermatophytes could also lead to pathologic inflammation and tissue damage to some extent.
  27. [27]
    A Current Diagnostic and Therapeutic Challenge: Tinea Capitis - NIH
    Jan 10, 2024 · Clinically, tinea capitis may present as a subtle hair loss accompanied by scalp scaling, alopecia with scaly patches, or alopecia with black ...
  28. [28]
    Tinea Capitis Clinical Presentation: History, Physical Examination ...
    Oct 2, 2024 · Dermatophyte idiosyncratic or id reactions are manifestations of the immune response to dermatophytosis. ... kerion formation. eMedicine ...
  29. [29]
    Diagnosis and Management of Tinea Infections - AAFP
    Nov 15, 2014 · There are three types of tinea capitis: gray patch, black dot, and favus. Black dot, caused by Trichophyton tonsurans, is most common in the ...
  30. [30]
    Tinea Capitis Differential Diagnoses - Medscape Reference
    Oct 2, 2024 · Differential Diagnoses · Alopecia Areata · Atopic Dermatitis · Drug Eruptions · Id Reaction (Autoeczematization) · Impetigo · Pediatric Syphilis.
  31. [31]
    Tinea Capitis (Scalp Ringworm) - Dermatologic Disorders
    Before draining a scalp abscess in a child, consider the diagnosis of kerion. Differential diagnosis of tinea capitis includes: Seborrheic dermatitis.
  32. [32]
    Topographic Differential Diagnosis of Chronic Plaque Psoriasis
    Nov 8, 2020 · Tinea capitis is usually more circumscribed, less diffuse than seborrheic dermatitis, or psoriasis unassociated with hair loss or broken-off ...
  33. [33]
    Tinea Capitis Presenting as Diffuse Hair Loss and Significance ... - NIH
    May 6, 2021 · Clinically, children present with pruritus, scaling, “black dots,” hair loss, and posterior cervical lymphadenopathy, whilst tinea capitis in ...
  34. [34]
    Wood's Light - StatPearls - NCBI Bookshelf
    Tinea capitis will reveal areas of baldness, and the Microsporum species ... The medical Wood's lamp contains a magnifying lens, a variety of phosphors ...
  35. [35]
    Wood lamp skin examination - DermNet
    Aug 8, 2014 · Tinea capitis—areas of scale and baldness due to fungal infection. ... Wood's lamp. Indian J Dermatol Venereol Leprol [serial online] 2004 ...Missing: clinical | Show results with:clinical
  36. [36]
    The Sensitivity and Specificity of Potassium Hydroxide Smear ... - NIH
    Apr 15, 2010 · The respective specificities for culture and KOH smear were 77.7% (72.2 to 82.5%) and 42.5% (36.6 to 48.6%). Conclusion. KOH smear and fungal ...
  37. [37]
    Tinea capitis: An update - Gupta - 2022 - Pediatric Dermatology
    Jan 24, 2022 · 2 DIAGNOSIS ; Microscopy, Sample is visualised after KOH or PAS stain, Fast, Moderate, Low ; Wood's lamp, UV light causes majority of ectothrix ...2 Diagnosis · 3 Laboratory Monitoring Of... · 4 Treatment/management
  38. [38]
    Tinea Capitis Workup: Laboratory Studies, Histologic Findings
    Oct 2, 2024 · Laboratory diagnosis of tinea capitis depends on examination and culture of skin rubbings, skin scrapings, or hair pluckings (epilated hair) from lesions.
  39. [39]
    PCR enables rapid detection of dermatophytes in practice
    Sep 17, 2024 · Fast and accurate results of PCR shorten the time to diagnosis and help clinicians to avoid possibly unnecessary empirical antifungal treatments ...
  40. [40]
    Real-Time PCR Assay for the Detection of Dermatophytes - NIH
    Nov 10, 2021 · This study aimed to compare two PCR assays for the diagnosis of dermatophytosis in outpatients at the Aristide Le Dantec University Hospital in Dakar, Senegal.
  41. [41]
    (PDF) Histopathology in the Diagnosis of Tinea Capitis: When to Do ...
    Jul 18, 2025 · In this article, histopathological findings of tinea capitis and several advantages and disadvantages of histopathology in the diagnosis of fungal infections ...
  42. [42]
    Tinea capitis caused by Trichophyton tonsurans presenting as ... - NIH
    The scalp biopsy revealed endothrix infection, and dermoscopic examination demonstrated the comma hair and corkscrew hair signs. The fungal culture showed ...
  43. [43]
    Asymptomatic Dermatophyte Carriers in the Households of Children ...
    Conclusions Initial prevalence of asymptomatic carriage of dermatophytes among household contacts of a child with tinea capitis was 16%, with 41% of carriers ...Missing: false | Show results with:false
  44. [44]
    Asymptomatic Scalp Carriage among Household Contacts of ... - NIH
    Dec 30, 2021 · The existence of asymptomatic carriers (ACs) could represent a potential reservoir responsible of (re)contamination and failure of treatment.Missing: false | Show results with:false
  45. [45]
    [PDF] Tinea Capitis: Current Concepts in Clinical Practice
    Tinea capitis is a common infection, particularly among young children in urban regions. The infection often is seen in a form with mild scaling.
  46. [46]
    A Current Diagnostic and Therapeutic Challenge: Tinea Capitis
    Jan 10, 2024 · Clinically, tinea capitis may present as a subtle hair loss accompanied by scalp scaling, alopecia with scaly patches, or alopecia with black ...
  47. [47]
    Tinea Capitis Often Overlooked in Adults - Advances in Dermatology
    Oct 7, 2016 · The Bottom Line · Tinea capitis should be included in the differential diagnosis of adults with scalp symptoms involving hair follicles.Missing: underdiagnosis | Show results with:underdiagnosis
  48. [48]
    Tinea capitis in adults: misdiagnosis or reappearance? - PubMed
    Background: According to the literature, tinea capitis in adults is supposed to be rare; we have recently observed a significant increase in cases.Missing: underdiagnosis | Show results with:underdiagnosis
  49. [49]
    Griseofulvin - StatPearls - NCBI Bookshelf - NIH
    Griseofulvin is FDA approved for and the drug of choice in tinea capitis. Other indications include onychomycosis as well as superficial fungal infections.
  50. [50]
    Tinea Capitis Treatment & Management - Medscape Reference
    Oct 2, 2024 · The duration of treatment should be between 4 and 6 weeks. Itraconazole, terbinafine, and fluconazole have been reported to be effective alternatives.
  51. [51]
    Meta-analysis of Randomized, Controlled Trials Comparing ...
    Conclusion: This meta-analysis suggests that terbinafine is more efficacious than griseofulvin in treating tinea capitis caused by Trichophyton species, whereas ...
  52. [52]
    An update on tinea capitis in children - Gupta - Wiley Online Library
    Aug 7, 2024 · Epidemiological analysis spanning from 1990 to 1993 and 2020 to 2023 reveals prevalence patterns of pediatric tinea capitis influenced by ...4 Discussion · 4.3 Diagnostic Approaches · 4.5 Treatment Strategies
  53. [53]
    Low utilization of confirmatory testing for tinea capitis by ... - Frontiers
    For systemic therapies, a systematic review of 38 TC clinical trials reported overall 92% and 72% complete cure rates for terbinafine and griseofulvin, ...
  54. [54]
    Case Report: Tinea Capitis in a 10-Year-Old Child - AAFP
    A systematic review found that griseofulvin was more effective for Microsporum species, whereas terbinafine (Lamisil) was equally or slightly more effective for ...
  55. [55]
    A Novel Itraconazole Pulse Therapy Schedule in the Treatment of ...
    Nov 25, 2021 · We report four cases of tinea capitis that were treated with a novel high-dose itraconazole pulse therapy (6–10 mg/kg/d with 3 weeks off between consecutive ...
  56. [56]
    Successful treatment of tinea capitis with 2% ketoconazole shampoo
    Ketoconazole 2% shampoo alone reduces the number of viable arthroconidia in children with tinea capitis thus reducing the transmissibility and contagious ...
  57. [57]
    Prophylactic Ketoconazole Shampoo for Tinea Capitis in a High ...
    Topical agents, including ketoconazole, continue to have a pivotal role as an adjunct to systemic therapy for the treatment and suppression of tinea capitis.
  58. [58]
    Tinea Capitis (+ 6 Natural Tips to Help Treat Scalp Ringworm)
    Jul 13, 2018 · Practice good hygiene, including washing and drying your hair daily when you have a fungal infection or hair fungus. · Keep your scalp dry and ...<|separator|>
  59. [59]
    Tinea Capitis: Symptoms, Causes & Treatment - Cleveland Clinic
    Mar 3, 2022 · Tinea capitis kerion are painful, pus-filled patches that sometimes ooze. A reaction to the fungus in your child's immune system causes kerion.Missing: formation | Show results with:formation<|control11|><|separator|>
  60. [60]
    In the treatment of kerion, is the addition of oral prednisone ... - LWW
    EVIDENCE-BASED ANSWER ... Not likely. The addition of oral prednisolone to griseofulvin therapy does not improve effectiveness at 12 weeks compared with ...
  61. [61]
    Kerion and tinea capitis - PMC - NIH
    Jun 28, 2018 · Kerion is a severe inflammatory form of tinea capitis with a hypersensitivity reaction against dermatophytes.Missing: supportive | Show results with:supportive
  62. [62]
    Treatment of Tinea Capitis | Skin Appendage Disorders
    Jan 17, 2019 · This paper will discuss the available antifungal agents that have shown high efficacy and safety profiles for this common infection.
  63. [63]
    Long-term Effectiveness of Treatment With Terbinafine vs ...
    Of the 72 patients who received subsequent terbinafine treatment, 63 (88%) achieved mycological cure and 55 (76%) achieved clinical cure. Conclusion In the ...
  64. [64]
    What is the best treatment for tinea capitis in an adult? - LWW
    When data were pooled for all 7 trials, the mean cure rate for griseofulvin 4 to 6 weeks posttreatment was 73%. Higher cure rates were seen for Microsporum (2 ...
  65. [65]
    Relapse after Oral Terbinafine Therapy in Dermatophytosis - NIH
    Thus, only 43% patients could achieve a long-term clinical and mycological cure after 2 weeks of oral terbinafine treatment. Majority of the relapses (16/22) ...
  66. [66]
    A Case of Terbinafine-Resistant Tinea Cruris Caused by ... - NIH
    Resistance of T. tonsurans against terbinafine could be due to the changes in the squalene epoxidase gene [6, 7] that was implied in patients with Trichophyton ...
  67. [67]
    Terbinafine-Resistant Dermatophytes and the Presence of ...
    Jul 11, 2023 · In the current study, we document a high rate of terbinafine resistance in Trichophyton isolates sent to our reference laboratory for testing ...Missing: capitis | Show results with:capitis
  68. [68]
    Tinea capitis: advances and a needed paradigm shift - PubMed
    Aug 1, 2021 · Trichophyton tonsurans is the predominant cause of tinea capitis in the USA, although the main gold standard of treatment in the USA is ...
  69. [69]
    A Current Diagnostic and Therapeutic Challenge: Tinea Capitis - MDPI
    Jan 10, 2024 · Tinea capitis typically requires systemic antifungal therapy. Griseofulvin, terbinafine, itraconazole, and fluconazole are the main antifungal agents used.
  70. [70]
    Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine ...
    Jul 6, 2025 · The existing literature carries varying results between the effectiveness of itraconazole pulse therapy and continuous terbinafine therapy in ...
  71. [71]
    Prophylactic Ketoconazole Shampoo for Tinea Capitis in a ... - NIH
    This study evaluated the effectiveness of a prophylactic ketoconazole shampoo (Nizoral 2%) protocol to reduce the number of clinically evident tinea capitis ...
  72. [72]
    Tinea Capitis - Causes, Symptoms, Diagnosis, and Treatment
    Apr 25, 2025 · Preventive measures include maintaining good hygiene, avoiding sharing personal items, regularly checking pets for fungal infections, and ...Tinea Capitis - Causes... · Tinea Capitis: Understanding... · Causes And Risk Factors
  73. [73]
    [PDF] ECE INSIDER - Cabinet for Health and Family Services
    Haircuts, shaving of the scalp, and wearing of head coverings are not indicated for treatment of tinea capitis.
  74. [74]
    Tinea Capitis (Ringworm of the Scalp) | Red Book - AAP Publications
    Once therapy is initiated, children should not be excluded from school. Family members and close contacts should be questioned regarding symptoms, and anyone ...Missing: screening | Show results with:screening
  75. [75]
    Ringworm or tinea (dermatophytosis) - Health.vic
    Oct 8, 2015 · Primary school and children's services centres exclusion for ringworm or tinea. Exclude until the day after appropriate treatment has commenced.
  76. [76]
    Additional measures for tinea capitis management – GPnotebook
    Dec 4, 2018 · cleansing of fomites. viable spores found in hairbrushes and combs should be cleansed with disinfectant e.g. - babers; simple bleach or a 2 ...
  77. [77]
    [PDF] Guidelines for the management of tinea capitis
    Cleansing of fomites. Viable spores have been isolated from hairbrushes and combs. For all anthropophilic species these should be cleansed with disinfectant.
  78. [78]
    Can bleach be used to treat ringworm? - Dr.Oracle AI
    Aug 11, 2025 · Household bleach can be used as an effective disinfectant for ringworm on hard, non-porous surfaces, but it is not recommended as a direct ...
  79. [79]
    Cutaneous Fungal Infections Caused by Dermatophytes and Non ...
    Jun 14, 2023 · The frequency of the disease ranges from 0.4% to 87.7% in Africa, 0.2% to 74.0% in America, 0.04% to 78.6% in Europe, and 0.01% to 91.2% in Asia ...
  80. [80]
    [PDF] The Global Impact of Tinea Capitis: Epidemiology and Public Health ...
    In developing countries, the prevalence is higher due to factors such as poor hygiene, overcrowding, and lack of access to medical care.Missing: incidence rates
  81. [81]
    Assessing the prevalence of tinea capitis in primary school children ...
    Nov 11, 2024 · Microsporum audouinii and Trichophyton soudanense are the most common in sub-Saharan West Africa while Trichophyton violaceum is the most ...<|separator|>
  82. [82]
    Pediatric Tinea Capitis: A Retrospective Cohort Study from 2010 to ...
    Mar 17, 2023 · Worldwide, tinea capitis is more common in populations with poor hygiene and lower socio-economic status [1,2]. For example, children attending ...Missing: race | Show results with:race
  83. [83]
    Tinea Capitis - an overview | ScienceDirect Topics
    The host reaction is variable, for while inflammation is minimal in populations living in endemic areas, severe inflammation, kerion formation, scarring, and ...
  84. [84]
    Dermatophyte infection (onychomycosis and tinea capitis)
    Tinea capitis is a pediatric disease that disproportionately affects children from socioeconomically disadvantaged backgrounds and sub-Saharan African descent.Missing: rural | Show results with:rural
  85. [85]
    Do Hair Care Practices Affect the Acquisition of Tinea Capitis?
    Conclusions Hair-grooming practices do not appear to play a major role in the acquisition of TC. Hair conditioners may be protective in children at risk for TC, ...Missing: clipping | Show results with:clipping
  86. [86]
    An observational cohort study among US children with Medicaid
    Dec 1, 2024 · Younger age, male sex, atopy, HIV infection, and immune-mediated inflammatory disease were independently associated with higher TC incidence.Missing: gender | Show results with:gender
  87. [87]
    Dermatophyte Infections Worldwide: Increase in Incidence and ...
    For example, tinea capitis is more prevalent in developing countries, while the prevalence of tinea pedis and onychomycosis is higher in developed countries [40] ...
  88. [88]
    The diagnosis and management of tinea capitis
    Gender distribution is approximately equal. Tinea capitis is the most common paediatric dermatophyte infection worldwide. Tinea capitis occurs occasionally ...
  89. [89]
    Tinea capitis in children: A single‐institution retrospective review ...
    Jan 17, 2021 · Among the 650 cases, 340 cases (48.2%) were males and 310 cases (51.8%) were females. The main population infected with tinea capitis was ...
  90. [90]
    Superficial Zoonotic Mycoses in Humans Associated with Cats - PMC
    Mar 24, 2024 · The results of other studies indicate that tinea capitis caused by M. canis mainly affects children aged 3–7 years and it is less common in ...
  91. [91]
    Tinea capitis: A current perspective - ScienceDirect
    During the past 50 years, the predominant etiologic agent of tinea capitis in the United States and in Western Europe has changed from Microsporum audouinii ...
  92. [92]
    Changing Epidemiology of Tinea Capitis in Athens, Greece - NIH
    Jun 27, 2023 · Over the years, the most commonly isolated dermatophyte species was M. canis, with a frequency ranging from 73% to 94%, regardless of the ...
  93. [93]
    Tinea capitis - PubMed
    In North America, tinea capitis is now predominantly due to Trichophyton tonsurans. During the past 100 years the most common North American organism for tinea ...
  94. [94]
    Tinea Capitis in California Children: A Population-based Study of a ...
    Apr 1, 1997 · Tinea capitis is epidemic among California children with higher rates in the northern counties studied. African-American children are the most affected by this ...
  95. [95]
    The epidemic of tinea capitis disproportionately affects school-aged ...
    The epidemic of tinea capitis disproportionately affects school-aged African Americans. Pediatr Dermatol. 1999 Jan-Feb;16(1):75. doi: 10.1046/j.Missing: 1990s | Show results with:1990s
  96. [96]
    Continuous increase of Trichophyton tonsurans as a cause of tinea ...
    Abstract. Tinea capitis (TC) is a highly contagious fungal infection of the scalp due to dermatophytes in children. To obtain information on the epidemiolo.
  97. [97]
    A systematic review of worldwide data on tinea capitis - ResearchGate
    May 31, 2025 · Tinea capitis (TC) – the most contagious fungal infection – is caused by anthropophilic, zoophilic and geophilic dermatophytes.
  98. [98]
    Epidemiological changes in tinea capitis over the sixty years of ...
    Aug 10, 2015 · ... disease patterns and the variability of ... In this study, we review all published clinical and etiological data of tinea capitis ...
  99. [99]
    Comprehensive Review of Tinea Capitis in Adults - MDPI
    May 16, 2024 · Previous estimates suggest that between 3% and 11% of all tinea capitis cases worldwide occur in adults, although updated epidemiological ...
  100. [100]
    Tinea Capitis (Scalp Ringworm) | Doctor - Patient.info
    Mar 22, 2023 · Oral antifungal treatment in primary care · Should be examined very carefully for signs of infection (may be just a few visible broken hairs).
  101. [101]
    [PDF] Ringworm of the Scalp (Tinea Capitis) - myPrivia
    They get better when you use antifungal medicine. Hair normally grows back 6 to 12 months after treatment. In the meantime, your child can wear a hat or scarf ...
  102. [102]
    Permanent Scarring in 25 % Patients with Kerion
    Feb 8, 2022 · Up to One Quarter of Patients with Kerion May have Permanent Scarring Hair Loss. Tinea capitis refers to a type of fungal infection of the scalp ...<|separator|>
  103. [103]
    Cutaneous, Subcutaneous and Systemic Mycology - PMC
    The first description of dermatophytosis was recorded by Celsus, a Roman encyclopaedist who described a suppurative infection of scalp.
  104. [104]
    Favus - StatPearls - NCBI Bookshelf - NIH
    May 29, 2023 · Favus is the most severe clinical type of tinea capitis. It is a chronic mutilating disease with serious familial and social implications.
  105. [105]
    Evolution of Knowledge of the Fungi and Mycoses from Hippocrates ...
    In 1837, a fungus (eventually, Trichophyton schoenleinii) was isolated from human favus (a dermatophytic infection of the scalp) by Schoenlein and Remak; ...
  106. [106]
    The ringworm children at the Hôpital Saint-Louis, Paris
    In 1892 Sabouraud was an intern in Besnier's department in Hôpital Saint-Louis. Besnier, acknowledged as the leader of French dermatology, encouraged his pupil ...
  107. [107]
    Tinea Corporis and Tinea Capitis | Pediatrics In Review
    May 1, 2007 · In the 1950s ... In 1958, treatment with oral griseofulvin was introduced, obviating the need to use epilation with radiography or thallium.
  108. [108]
    Griseofulvin: An Updated Overview of Old and Current Knowledge
    Oct 18, 2022 · Griseofulvin is an antifungal polyketide metabolite produced mainly by ascomycetes. Since it was commercially introduced in 1959, griseofulvin has been used in ...Missing: 1950s | Show results with:1950s
  109. [109]
    Diagnosis and management of scalp ringworm - PMC - NIH
    Scalp ringworm, or tinea capitis, largely disappeared in Great Britain after oral griseofulvin was introduced in the late 1950s. Over the past few years ...
  110. [110]
    An epidemic of infection with Trichophyton tonsurans ... - PubMed
    Over the past 20 years, T. tonsurans has emerged as a major cause of both tinea capitis and tinea corporis in Chicago.Missing: 1970s Western countries<|separator|>
  111. [111]
    Advancing management of tinea capitis through dermatophyte PCR
    May 31, 2024 · Dermatophyte PCR is an excellent tool for baseline diagnostics of TC providing rapid and accurate results.
  112. [112]
    Time to Think Antifungal Resistance Increased ... - PubMed Central
    Mar 5, 2024 · Increased antifungal resistance is exacerbating the burden of invasive fungal infections, as well as potentially contributing to the increase in resistant ...